
April 29 (Reuters) - Entrada Therapeutics Inc TRDA.O:
ENTRADA THERAPEUTICS INC - APPROVES STRATEGIC PLAN FOCUSING ON DMD PROGRAMS - SEC FILING
ENTRADA THERAPEUTICS INC - TO REDUCE WORKFORCE BY APPROXIMATELY 20% UNDER NEW PLAN - SEC FILING
ENTRADA THERAPEUTICS INC - EXPECTS CASH RUNWAY TO EXTEND INTO Q2 2027 - SEC FILING
Source text: [ID:n0001104659-25-041204]